Evaluating the impact of Relative Total Dose Intensity (RTDI) on patients' short and long-term outcome in taxane- and anthracycline-based chemotherapy of metastatic breast cancer- a pooled analysis
Date Issued
2011-01-01
Author(s)
Loibl, Sibylle
Skacel, Tomas
Nekljudova, Valentina
Lück, Hans Joachim
Brodowicz, Thomas
Zielinski, Christoph
von Minckwitz, Gunter
DOI
10.1186/1471-2407-11-131
Abstract
Chemotherapy dose delay and/or reduction lower relative total dose intensity (RTDI) and may affect short- and long-term outcome of metastatic breast cancer (MBC) patients.